Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC

Although the etoposide and carboplatin (EP) combination strategy has been the first-line chemotherapy, patients with extensive-stage disease small-cell lung cancer (SCLC) still have poor survival outcomes. Our retrospective analysis revealed that 46 patients with SCLC only achieved medium overall su...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Zhang, Kuai, Xingwang, Wang, Guangwei, Liu, Sanfeng, Liu, Kai, Zhang, Heng, Xia, Shujing, Zhu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762851/
https://www.ncbi.nlm.nih.gov/pubmed/35612299
http://dx.doi.org/10.1080/10717544.2022.2039803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762851/
https://www.ncbi.nlm.nih.gov/pubmed/35612299
http://dx.doi.org/10.1080/10717544.2022.2039803

Ejemplares similares